Ovarian Cancer Awareness Month
March is Ovarian Cancer Awareness Month, a yearly campaign led by organisations such as Ovarian Cancer Action which aims to spread the word about symptoms, risk factors, and early diagnosis of ovarian cancer.
Here at EssexPrivateGP, we believe that understanding the connections between ovarian cancer, menopause, and hormone replacement therapy (HRT) is an important step in empowering women to take charge of their health.
Below, we explore these links in more detail, and share news about a promising ovarian cancer vaccine that’s currently under development.
Ovarian cancer awareness
Ovarian cancer can be tricky to detect in its early stages. Symptoms may include persistent bloating, abdominal pain, feeling full quickly, or needing to urinate more often. Yet, these signs can sometimes overlap with other conditions.
It’s also worth bearing in mind that awareness extends beyond just knowing the symptoms. Genetic predisposition (such as BRCA gene mutations) can raise your risk, and lifestyle factors like diet, exercise, and stress may play a role in your overall health.
As there’s no surefire method of preventing ovarian cancer, taking note of family history and staying vigilant about any unusual changes in your body can prove invaluable. In many cases, scheduling regular check-ups or discussing any concerns with a GP can offer peace of mind and help detect issues early on.
The link between menopause, HRT, and ovarian cancer
Menopause is a natural stage in a woman’s life, but it can bring about a host of physical and emotional changes. Hot flushes, night sweats, and mood swings are just a few of the symptoms that can have a real impact on day-to-day living. It’s also important to note that fluctuations in hormones around perimenopause and postmenopause can sometimes mask early signs of ovarian issues.
In some cases, hormone replacement therapy (HRT) may be prescribed to help alleviate these symptoms by replenishing the body’s levels of oestrogen and progesterone. However, questions occasionally arise regarding how HRT may affect the risk of ovarian cancer. While certain studies have suggested that prolonged use of HRT could slightly increase the likelihood of developing ovarian cancer, it’s important to bear in mind that the absolute risk remains relatively low for many women.
At EssexPrivateGP, we have a dedicated team of GPs with experience in menopause care that will listen to your concerns and can provide personalised advice, including whether HRT is right for you. We take factors such as your family history and any underlying medical conditions into account before guiding you towards the most suitable course of action.
New promising vaccine in development
Although ovarian cancer continues to pose challenges in terms of early detection and treatment, there is encouraging news on the horizon. Researchers are working on a vaccine designed to boost the body’s immune response against ovarian cancer cells, aiming to improve survival rates for those affected.
According to Ovarian Cancer Action, this development has the potential to transform the way we tackle the disease by offering a more targeted and personalised form of protection.
While the vaccine is still undergoing testing, the preliminary results are promising. The hope is that, in the not-too-distant future, this new approach could become a viable option for women at higher risk of ovarian cancer or those who are already undergoing treatment.
Although it may be some time before the vaccine is widely available, these advances highlight the critical role that continued research and collaboration play in the fight against ovarian cancer.
If you’re experiencing any unusual symptoms, have a family history of ovarian cancer, or are currently going through menopause and wondering about HRT, please don’t hesitate to get in touch with our friendly team. We’re here to listen, answer your questions, and guide you toward the support and information you need.
